This Value Stock Just Had a Big Breakout and is Set to Climb Higher
We’re targeting a 10%-17% potential return in the next 3-6 months.
Read Moreby Tara Young and Greg Patrick, Trades of the Day | Apr 30, 2026
We’re targeting a 10%-17% potential return in the next 3-6 months.
Read Moreby Leo Sun, The Motley Fool | Apr 30, 2026
Long-term investors can look past the market’s near-term challenges and still find some attractive growth plays despite the volatility.
Read Moreby Brett Owens, Contrarian Outlook | Apr 30, 2026
Both of these names have a growing dividend, a history of share buybacks, and a high ‘shareholder yield.’
Read Moreby Marc Lichtenfeld, Wealthy Retirement | Apr 30, 2026
If this were a stock, I’d be eager to buy it, as it’s in an uptrend and coming into support with momentum starting to shift.
Read Moreby TheFly.com | Apr 30, 2026
Here are today’s upgrades and downgrades: Meta Platforms, Qualcomm, AbbVie, AstraZeneca, Teradyne, Oneok, Wingstop and more.
Read Moreby Tara Young and Greg Patrick, Trades of the Day | Apr 29, 2026
We’re targeting a 20%-32% potential return in the next 3-6 months.
Read Moreby Michael Foster, Contrarian Outlook | Apr 29, 2026
Trading at too big of a gap to last, it holds some of the strongest companies in America: NVIDIA (NVDA), Microsoft (MSFT), Alphabet (GOOGL), Visa (V) and Capital One Financial (COF).
Read Moreby Anthony Di Pizio, The Motley Fool | Apr 29, 2026
Trading 24% and 17% off from their respective peaks might spell opportunity.
Read Moreby Brett Eversole, DailyWealth.com | Apr 29, 2026
According to history, we can expect big returns in the months ahead.
Read Moreby TheFly.com | Apr 29, 2026
Here are today’s upgrades and downgrades: Elevance Health, MercadoLibre, Centene, Nokia, Boston Scientific, Sysco, Brown-Forman and more.
Read Moreby Tara Young and Greg Patrick, Trades of the Day | Apr 28, 2026
We’re targeting a 17%-29% potential return in the next 3-6 months.
Read Moreby Bryan Hayes, Zacks | Apr 28, 2026
Advancing over 300% already this year, it stands out as a high-conviction idea, offering a balanced risk/reward profile with tangible earnings momentum.
Read More
